Meridian™
Universe

ZYBT · CIK 0001975641 · FY2025 live · 2025-12-31

Zhengye Biotechnology Holding Ltd

DistressEntered vs prior FYSEC 10-KClassic ZHealthcare65th percentile in Healthcare · 736 names

View as

Model

Classic Z

FY2025

0.87

Zone

Distress

vs FY2024

−1.07

Market DD

—

1y PD

—

0.87

Z″ 1.03

−21.83.08+

Score 0.87 · distress below 1.80, grey to 2.99, safe at 3.00 and above.

Classic Z factor contributions

  • X1 Working capital / assets

    Short-term liquidity versus the size of the balance sheet.

    0.04
    1.2 × = 0.05

  • X2 Retained earnings / assets

    Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.

    −0.05
    1.4 × = −0.07

  • X3 EBIT / assets

    Operating return on assets. Highest weight in the original model.

    −0.16
    3.3 × = −0.53

  • X4 Book equity / liabilities

    Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.

    1.92
    0.6 × = 1.15

  • X5 Sales / assets

    Asset turnover — how much revenue the asset base supports.

    0.27
    1 × = 0.27

Five-year path

Z plus liquidity (working capital / assets) and earnings (EBIT / assets) over the last 2 annual filings.

Meridian Rank

32.53

0–100 · Classic Z family

  • Book standing

    44

  • Year change

    7

  • Market PD

    —

  • O-score

    36

Events on this name

Same published rows as Today.

  • Entered distress

    high · 80

    • Zone: Grey → Distress
    • Live score: 1.94 → 0.87
    • Meridian Rank: 32.80 → 32.53

Overview

rule-v1

Zhengye Biotechnology Holding Ltd is on classic Z at 0.87 (distress) for FY2025, from an SEC 10-K. Book equity / liabilities is the line that sets the print. It entered distress from grey (FY2024 1.94). No market tape loaded. Classic Z was fit on manufacturers. Buybacks can send retained earnings negative at otherwise healthy issuers. X4 is book equity.

Book screen Distress; market PD —. Market PD has not been priced on this name.

Market DD · naive Merton

No market tape yet.

Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.

Sector peers

Closest Classic Z scores · 65th percentile in Healthcare.

Filing line items

Current assets

$20M

Total assets

$62M

Current liabilities

$17M

Total liabilities

$19M

Working capital

$2M

Retained earnings

−$3M

EBIT

−$10M

Total sales

$17M

Book equity

$36M

Accession 0001213900-26-048584. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as is a display overlay. X4 is book equity. Pulled 13 Sept 2026.